| Aaron Michael Mulhall, | |
|
110 Layman Ln, Elizabethtown, KY 42701-2523 | |
| (270) 706-5787 | |
| (270) 706-5788 |
| Full Name | Aaron Michael Mulhall |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 14 Years |
| Location | 110 Layman Ln, Elizabethtown, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801113576 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 48800 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hardin Memorial Hospital | Elizabethtown, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Baptist Health Medical Group Inc | 5597867184 | 1912 |
News Archive
Collated Childhood cancer statistics in sub-Saharan Africa have been published for the first time as a monograph in the peer reviewed journal ecancermedicalscience, allowing researchers and policymakers a critical new insight into the impact of pediatric cancer across this region.
Differential H3K27AC marks were identified at enhancer regions of genes including c-MYC, MED1, OCT-4, NANOG, and SOX2 that can act as super-enhancers (SE), cluster of genes in non-cancerous, cancerous and metastatic PDAC cell lines.
Instem, a leading provider of early drug development software solutions, announced today details of their newest product line, Centrus™, for enterprise information integration in early drug development. Centrus provides a single, secure environment to access, harmonize and use early drug development information from a variety of sources, including current data acquisition systems, legacy systems, warehouses, partner and contract research applications, to meet the rapidly-expanding needs of life science organizations for data-driven decision making.
India's Prime Minister Manmohan Singh on Tuesday during the launch of the Third World Academy of Sciences meeting (TWAS) in Hyderabad, India, called for developing countries to place greater emphasis on scientific research and application, the Economic Times reports.
As co-ordinator of the European project ‘ReBioStent', Ceram, the international materials technology company, is pleased to announce that the project, to develop new biomaterials and new arterial stents, has been awarded Euro 5.874M by the European Union.
› Verified 1 days ago
| Entity Name | Hardin Professional Services, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306894704 PECOS PAC ID: 9739191628 Enrollment ID: O20060614000061 |
News Archive
Collated Childhood cancer statistics in sub-Saharan Africa have been published for the first time as a monograph in the peer reviewed journal ecancermedicalscience, allowing researchers and policymakers a critical new insight into the impact of pediatric cancer across this region.
Differential H3K27AC marks were identified at enhancer regions of genes including c-MYC, MED1, OCT-4, NANOG, and SOX2 that can act as super-enhancers (SE), cluster of genes in non-cancerous, cancerous and metastatic PDAC cell lines.
Instem, a leading provider of early drug development software solutions, announced today details of their newest product line, Centrus™, for enterprise information integration in early drug development. Centrus provides a single, secure environment to access, harmonize and use early drug development information from a variety of sources, including current data acquisition systems, legacy systems, warehouses, partner and contract research applications, to meet the rapidly-expanding needs of life science organizations for data-driven decision making.
India's Prime Minister Manmohan Singh on Tuesday during the launch of the Third World Academy of Sciences meeting (TWAS) in Hyderabad, India, called for developing countries to place greater emphasis on scientific research and application, the Economic Times reports.
As co-ordinator of the European project ‘ReBioStent', Ceram, the international materials technology company, is pleased to announce that the project, to develop new biomaterials and new arterial stents, has been awarded Euro 5.874M by the European Union.
› Verified 1 days ago
| Entity Name | Baptist Health Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922401611 PECOS PAC ID: 5597867184 Enrollment ID: O20150219000942 |
News Archive
Collated Childhood cancer statistics in sub-Saharan Africa have been published for the first time as a monograph in the peer reviewed journal ecancermedicalscience, allowing researchers and policymakers a critical new insight into the impact of pediatric cancer across this region.
Differential H3K27AC marks were identified at enhancer regions of genes including c-MYC, MED1, OCT-4, NANOG, and SOX2 that can act as super-enhancers (SE), cluster of genes in non-cancerous, cancerous and metastatic PDAC cell lines.
Instem, a leading provider of early drug development software solutions, announced today details of their newest product line, Centrus™, for enterprise information integration in early drug development. Centrus provides a single, secure environment to access, harmonize and use early drug development information from a variety of sources, including current data acquisition systems, legacy systems, warehouses, partner and contract research applications, to meet the rapidly-expanding needs of life science organizations for data-driven decision making.
India's Prime Minister Manmohan Singh on Tuesday during the launch of the Third World Academy of Sciences meeting (TWAS) in Hyderabad, India, called for developing countries to place greater emphasis on scientific research and application, the Economic Times reports.
As co-ordinator of the European project ‘ReBioStent', Ceram, the international materials technology company, is pleased to announce that the project, to develop new biomaterials and new arterial stents, has been awarded Euro 5.874M by the European Union.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Aaron Michael Mulhall, 3624 Legend Oaks Dr, Amelia, OH 45102-1281 Ph: (502) 419-2342 | Aaron Michael Mulhall, 110 Layman Ln, Elizabethtown, KY 42701-2523 Ph: (270) 706-5787 |
News Archive
Collated Childhood cancer statistics in sub-Saharan Africa have been published for the first time as a monograph in the peer reviewed journal ecancermedicalscience, allowing researchers and policymakers a critical new insight into the impact of pediatric cancer across this region.
Differential H3K27AC marks were identified at enhancer regions of genes including c-MYC, MED1, OCT-4, NANOG, and SOX2 that can act as super-enhancers (SE), cluster of genes in non-cancerous, cancerous and metastatic PDAC cell lines.
Instem, a leading provider of early drug development software solutions, announced today details of their newest product line, Centrus™, for enterprise information integration in early drug development. Centrus provides a single, secure environment to access, harmonize and use early drug development information from a variety of sources, including current data acquisition systems, legacy systems, warehouses, partner and contract research applications, to meet the rapidly-expanding needs of life science organizations for data-driven decision making.
India's Prime Minister Manmohan Singh on Tuesday during the launch of the Third World Academy of Sciences meeting (TWAS) in Hyderabad, India, called for developing countries to place greater emphasis on scientific research and application, the Economic Times reports.
As co-ordinator of the European project ‘ReBioStent', Ceram, the international materials technology company, is pleased to announce that the project, to develop new biomaterials and new arterial stents, has been awarded Euro 5.874M by the European Union.
› Verified 1 days ago
John A Godfrey, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 914 N Dixie Ave, Ste 304, Elizabethtown, KY 42701 Phone: 270-769-1049 Fax: 270-735-1978 | |
Dr. Charles Kenny Maffet, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 105 Diecks Dr, Elizabethtown, KY 42701 Phone: 270-737-6300 | |
Mallory Ann Doyle, AGPCNP Pulmonary Disease Medicare: May Accept Medicare Assignments Practice Location: 105 Financial Pl, Elizabethtown, KY 42701 Phone: 270-765-5112 | |
Mahendra M Patel, M.D. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 105 Financial Pl Ste 105, Elizabethtown, KY 42701 Phone: 270-765-5112 Fax: 270-737-9252 | |
Dr. Scott Raymond Monnin, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1324 Woodland Dr Ste A, Elizabethtown, KY 42701 Phone: 270-765-5921 Fax: 270-982-3324 | |
Mrs. Vivian H Bland, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 914 N Dixie Ave, Suite 306, Elizabethtown, KY 42701 Phone: 270-769-1559 Fax: 270-234-9152 | |
Dr. Kamal Moulana, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1240 Woodland Dr, Elizabethtown, KY 42701 Phone: 270-769-9881 Fax: 270-769-9589 |